EBay to Settle DOJ's Pill Press Probe for $59 Million
By Dean Seal
EBay will pay $59 million to settle the federal government's allegations that thousands of pill presses and encapsulating machines were sold on its popular online marketplace.
The Department of Justice said Wednesday that eBay has also agreed to enhance its compliance program in order to resolve claims that the pill press and encapsulating machine sales on its platform violated the Controlled Substances Act.
The government claims that hundreds of pill press buyers on eBay also purchased counterfeit molds, stamps or dies needed to produce pills that mimic the products of legitimate pharmaceutical companies. Many of those buyers have since been prosecuted in connection with trafficking illegal counterfeit pills, the DOJ said.
According to the settlement agreement, eBay denied the federal government's contention that it is subject to the Controlled Substances Act and doesn't admit liability in connection with the allegations.
A spokesperson for eBay didn't immediately respond to a request for comment.
The Justice Department is calling the agreement its fourth-largest Controlled Substances Act settlement ever and its first with an e-commerce company.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
January 31, 2024 10:53 ET (15:53 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom